Merus (MRUS) receives milestone payment from Ono Pharma (OPHLY) for selection of bispecific antibody candidate for clinical development and extends partnership with CMC service agreement.
In: Chemical Business Newsbase, 2016-10-19
Zeitungsartikel
Zugriff:
Titel: |
Merus (MRUS) receives milestone payment from Ono Pharma (OPHLY) for selection of bispecific antibody candidate for clinical development and extends partnership with CMC service agreement.
|
---|---|
Zeitschrift: | Chemical Business Newsbase, 2016-10-19 |
Veröffentlichung: | 2016 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|